LIN.US

472.98

+0.63%↑

SHW

357.59

+0.03%↑

ECL

267.29

+0.26%↑

SCCO

95.64

-0.3%↓

AEM

117.91

-3.38%↓

LIN.US

472.98

+0.63%↑

SHW

357.59

+0.03%↑

ECL

267.29

+0.26%↑

SCCO

95.64

-0.3%↓

AEM

117.91

-3.38%↓

LIN.US

472.98

+0.63%↑

SHW

357.59

+0.03%↑

ECL

267.29

+0.26%↑

SCCO

95.64

-0.3%↓

AEM

117.91

-3.38%↓

LIN.US

472.98

+0.63%↑

SHW

357.59

+0.03%↑

ECL

267.29

+0.26%↑

SCCO

95.64

-0.3%↓

AEM

117.91

-3.38%↓

LIN.US

472.98

+0.63%↑

SHW

357.59

+0.03%↑

ECL

267.29

+0.26%↑

SCCO

95.64

-0.3%↓

AEM

117.91

-3.38%↓

Search

Avantor Inc

Geschlossen

BrancheRohstoffe

13.07 1

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.95

Max

13.38

Schlüsselkennzahlen

By Trading Economics

Einkommen

-440M

60M

Verkäufe

-105M

1.6B

KGV

Branchendurchschnitt

12.462

62.538

EPS

0.23

Gewinnspanne

3.819

Angestellte

13,500

EBITDA

-491M

239M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+36.68% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

25. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.5B

8.8B

Vorheriger Eröffnungskurs

12.07

Vorheriger Schlusskurs

13.07

Nachrichtenstimmung

By Acuity

50%

50%

84 / 169 Ranking in Basic materials

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Avantor Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Mai 2025, 14:02 UTC

Akquisitionen, Fusionen, Übernahmen

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

25. Apr. 2025, 13:52 UTC

Ergebnisse
Wichtige Markttreiber

Avantor Shares Fall on Cut Guidance, Lower Demand

25. Apr. 2025, 11:02 UTC

Ergebnisse

Avantor Cuts Outlook as Policy Shifts Dent Demand in Certain Markets

28. Mai 2025, 13:47 UTC

Akquisitionen, Fusionen, Übernahmen

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

Peer-Vergleich

Kursveränderung

Avantor Inc Prognose

Kursziel

By TipRanks

36.68% Vorteil

12-Monats-Prognose

Durchschnitt 17.7 USD  36.68%

Hoch 30 USD

Tief 14 USD

Basierend auf 17 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avantor Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

17 ratings

10

Buy

7

Halten

0

Sell

Technischer Score

By Trading Central

11.965 / 12.57Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

84 / 169 Ranking in Rohstoffe

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Avantor Inc

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.